Timothy Cruz
District Attorney
Plymouth County District Attorney's Office
Timothy J. Cruz has served as the Plymouth County District Attorney since November, 2001. During his tenure he has aggressively prosecuted crime in Plymouth County. Most recently, Cruz has focused his office’s efforts on battling the opioid crisis at all levels. His office also works collaboratively with local law enforcement, social service agencies, healthcare professionals, the faith community and educators on crime prevention initiatives throughout the county. Cruz has served as a member of the Massachusetts Office for Victim Assistance; Department of Corrections Advisory Council; Governor’s Council on Capital Punishment; and the Forensic Technology Subcommittee of the Governor’s Commission on Criminal Justice Innovation. He has also served two terms as the President of the Massachusetts District Attorneys Association. Previously, he worked in private practice, and as an Assistant District Attorney in Plymouth County. He is a graduate of Boston College and Suffolk University Law School and is admitted to both the Massachusetts and the United States District Court bars, as well as the United States Court of Appeals and the Supreme Court of the United States.

John Dyben, DHSc, MCAP, CMHP, ICAD
Chief Clinical Officer
Origins Behavioral Healthcare
John Dyben serves as the chief clinical officer for Origins Behavioral Healthcare, providing academic and clinical supervisory support. His background includes degrees in psychology and health science, with his doctoral practicum having focused on the dynamics, epidemiology and treatment of substance use and addiction in older adults. Dyben is an ordained pastor, clinically trained chaplain and board certified as a master addictions professional and a mental health professional in the State of Florida as well as an internationally certified alcohol and drug counselor, substance abuse professional and certified MBTI practitioner. Dyben’s responsibilities at Hanley Center at Origins have included clinical director, director of older adult and boomer recovery, director of spirituality and director of men’s recovery. He also has experience in community-based mental health and wellness fields, which included therapeutic and administrative positions with Boys Town USA. He has been an adjunct faculty member at Palm Beach State College and a faculty member of the Addiction Professionals Training Institute in West Palm Beach, Florida.

John Eadie, MPA
Coordinator, Public Health and Prescription Drug Monitoring Program Project
National Emerging Threat Initiative, A National HIDTA Initiative
John Eadie is the Public Health & Prescription Drug Monitoring Program project coordinator for the National Emerging Threat Initiative of the National HIDTA Assistance Center. He previously served as director of the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University (2010-2015). For 44 years, Eadie has served in management, executive and consulting capacities in the field of public health. As director of the Division of Public Health Protection in the New York State Department of Health (1985-1995), he directed the state’s pharmaceutical diversion program, including the PDMP. He co-founded both the Alliance of States with Prescription Monitoring Programs and the National Association of State Controlled Substances Authorities, served as president for both organizations and held other posts. Since leaving New York state service in 2001, Eadie has served as a consultant on PDMPs, including serving as the administrative reviewer for the Massachusetts PDMP.

David Fawcett PhD, LCSW
Sex Therapist

David Fawcett PhD, LCSW, is a social worker and sex therapist in Fort Lauderdale, Florida, specializing in gay men’s health. He is the author of “Lust, Men, and Meth: A Gay Man’s Guide to Sex and Recovery,” which explores the intersection of gay men, drug use and high-risk sexual behavior. Fawcett is currently consulting on a variety of diverse projects, including a documentary on chemsex, capacity building for addictions treatment among LGBT youth in Hong Kong, and the development of treatment protocols for stimulant misuse among MSM for the European Union. He frequently presents workshops on LGBT health, addiction, HIV, and co-occurring disorders, and has served on the Project Coordinating Committee for SAMHSA’s HIV and Mental Health Training and Resource Center. He has also been featured on SAMHSA’s “Road to Recovery” television series.

Mark Gold, MD
Cocaine and Addiction Researcher
Mark S. Gold, MD, is a teacher, translational researcher, author, mentor and inventor best known for his work on the brain systems underlying the effects of opiate drugs, cocaine and food. He has worked as an advisor to several White House drug czars, National Institute on Drug Abuse directors and National Institute of Mental Health directors over his more than 40-year career. Gold was co-inventor of the use of clonidine in opioid withdrawal and the dopamine hypothesis for cocaine addiction and anhedonic withdrawal. He pioneered the use of clonidine and lofexidine in the late 1970s and early 1980s. Gold has earned a number of national awards for his research, including the Foundations Fund Prize, the McGovern Award for Lifetime Achievement, the National Leadership Award from the National Association of Addiction Treatment Providers, the DARE Lifetime Achievement Award and the PATH Foundation’s Lifetime Achievement Award--presented to him by drug czar Michael Botticelli. He was awarded distinguished alumni awards from Yale University and Washington University.

Jim Hall, PhD
Senior Epidemiologist
Center for Applied Research on Substance Use and Health Disparities Nova Southeastern University
James N. Hall is a drug abuse epidemiologist affiliated with Nova Southeastern University’s Center for Applied Research on Substance Abuse and Health Disparities. He is the Miami-based member of the National Institute on Drug Abuse’s Community Epidemiology Work Group. Hall compiles local drug use data including hospitalizations, deaths, addiction treatment and prevalence, as well as drug pricing, strength and abuse trends. He works closely with local drug use coalitions, law enforcement and other community organizations. Hall served as the executive director of Up Front Drug Information and Education Center in Miami from 1982-2012 and was the recipient of the 2010 Path of Public Health Award for Epidemiology and Disease Surveillance Services from Florida International University.

Norman Hoffmann, PhD
Evince Clinical Assessments
Norman G. Hoffmann, PhD, president of Evince Clinical Assessments, is an internationally recognized expert in the development of scientifically sound assessment instruments and the evaluation of behavioral health treatment programs. The instruments include brief and comprehensive interviews for the identification of mental health and substance use disorders in accordance with current diagnostic criteria as well as treatment planning aids based on the American Society of Addiction Medicine Criteria. Hoffmann has provided consultation services on assessment and evaluation issues for state and federal agencies, corporations and public organizations in the U.S., Canada, Sweden and Norway. Hoffmann led the team that developed the first placement criteria for multiple levels of care and was the lead author on the first American Society of Addiction Medicine patient placement criteria. His work on treatment evaluation provided evidence for the societal and financial benefits from addictions treatment and a foundation for empirically supported funding of treatment services. Additionally, Hoffmann served on first joint accreditation panel for prisons, probation, and parole in the United Kingdom. His publications include more than 200 articles, book chapters, and other publications. Hoffmann received his doctorate in clinical psychology from the University of Minnesota. Although employed largely in the private sector, his faculty appointments include the University of Texas Medical Branch, University of Minnesota, and Brown University. He is currently adjunct professor of psychology at Western Carolina University

Dana Hunt, PhD
Principal Scientist
Abt Associates
Dana Eser Hunt, PhD, is a widely recognized expert with over 35 years of experience in research in alcohol and drug use and methodological issues in the field. She has managed several large multi-site research projects for the National Institute on Drug Abuse, the Office of National Drug Control Policy (ONDCP) and the National Institute of Justice, including a 35 site Arrestee Drug Abuse Monitoring program. Hunt also currently serves as senior staff on ONDCP’s High Intensity Drug Trafficking Area (HIDTA) performance audit project, examining each of the HIDTA task force’s performance in stemming high level drug trafficking.

Edward Jacoubs, MSW
Director of Grants and Sponsored Projects
Plymouth County District Attorney's Office
Edward Jacoubs is director of grants and special projects for the Plymouth County District Attorney’s Office. He brings to the board experience designing and implementing programs for off-track youth, and he has authored and received numerous grants focused on supporting Map Academy’s target population. Jacoubs will help facilitate change for high-risk youth through his deep connections to local organizations that can provide resources and supports to Map Academy students and families. Additionally, he is the chair of the Map Academy Board of Trustees.

Hotse Langeraar
Meridian Treatment Solutions

Krista McCormick
Manager, NPLEx/MethCheck & Subpoena Compliance
Appriss Health
Krista has been with Appriss for 11 years and has worked on NPLEx (National Precursor Log Exchange) since its inception. She has extensive experience with domestic meth production policy. She has been a part of every statewide NPLEx implementation and currently manages all 37 states focusing on driving program awareness. Krista serves as the subject matter expert for NPLEx and has presented to multiple law enforcement groups, pharmacists, and prosecutors. Krista has also testified in federal and state court all over the country.

Justin Miller, PhD
Field Intelligence Manager, DEA Miami Field Division
Dr. Justin L. Miller currently serves as the Field Intelligence Manager for the Drug Enforcement Administration’s Miami Field Division. In this position, he leads the division’s Intelligence Program throughout the state of Florida, with responsibilities that include managing the collection, analysis, and dissemination of intelligence to identify and target for enforcement action significant drug trafficking organizations impacting the United States, and the production of strategic assessments on drug trafficking trends, emerging threats, and other national security concerns. He also serves as the division’s principal coordinator with the intelligence components of state, local, and other federal law enforcement agencies and the Intelligence Community. His previous leadership positions include supervising the DEA Intelligence unit in McAllen, Texas that covers the South Texas-Mexico border area, and directing the Financial Intelligence and Strategic Targeting units at DEA Headquarters. Dr. Miller also served at the El Paso Intelligence Center in El Paso, Texas, and in the DEA office in Cartagena, Colombia. Dr. Miller holds an M.A. and a Ph.D. from Baylor University.

Siobhan Morse MHSA, CRC, CAI, MAC
Division Director of Clinical Services
Foundations Recovery Network

As director of clinical services, Siobhan Morse is charged with spearheading the research, clinical operations management and new product development for Foundations Recovery Network within Universal Health Services, Inc. Morse regularly presents original research worldwide and recently co-authored “A Comparison of Opioid and Non-opioid Substance Users in Residential Treatment for Co-Occurring Substance Use and Mental Disorders.” Morse joined Foundations Recovery Network in 2012 as director of research and fidelity after having served for six years as executive director for the National Institute for Holistic Addiction Studies. Earlier in her career, she conducted clinical trials supporting new drug development for pharmaceutical manufacturers, including Marion Merrell Dow, Pfizer and others.

Jules Netherland, PhD
Drug Policy Alliance
Julie “Jules” Netherland, PhD, is the Director of the Office of Academic Engagement for the Drug Policy Alliance. In that role, she advances drug policy reform by supporting scholars in doing advocacy, convening experts from a range of disciplines to inform the field, and strengthening DPA’s use of research and scholarship in developing and advancing its policy positions.

Lia Pizzicato
Philadelphia Department of Public Health
Lia Pizzicato is the CDC/CSTE Applied Epidemiology Fellow at the Philadelphia Department of Public Health. Lia conducts epidemiology research and data analyses projects on substance use and mental health by developing and updating Philadelphia’s Opioid Misuse and Overdose Surveillance Dashboard, utilize Medicaid claims data to understand opioid prescribing trends in Philadelphia, and analyzing unintentional drug overdose fatality data to understand emerging trends in drug use. Prior to joining the Philadelphia Department of Public Health, Lia was a research assistant with the Connecticut Emerging Infections Program, where she conducted surveillance for E. coli, Salmonella, Campylobacter and other reportable enteric diseases; collected patient information from healthcare providers and local health departments & interviewed patient about their illnesses and exposures; maintained patient data in Maven Disease Surveillance Outbreak Management System and carried-out patient interviews during outbreak investigation of foodborne illnesses

Howard Rosen
Assistant State Attorney, Deputy Chief for Special Prosecutions
Miami-Dade County State Attorney’s Office Eleventh Judicial Circuit of Florida
Howard Rosen is the Deputy Chief Assistant State Attorney for Special Prosecutions at the Miami-Dade County State Attorney’s Office, where he has supervisory responsibilities over all Public Corruption, Organized Crime, Narcotics, Gang, Insurance Fraud, Economic Crimes, and Cyber Crimes investigations and prosecutions.

Craig Rush, PhD
University of Kentucky
Craig Rush. PhD, has been active in the areas of research, teaching, service and administration. He served as the principal investigator on a number of projects from the National Institute on Drug Abuse. Rush is also the principal investigator on a subcontract from the University of Vermont and is a co-investigator on at least five other National Institutes on Health-funded projects. During 2017, Rush continued his role as director of a T32 awarded to the University of Kentucky entitled. "Research Training in Drug Abuse Behavior." He submitted at least six R01 grant applications to the National Institutes on Health as principal investigator for consideration for funding. Additionally, Rush published four manuscripts during 2017 and has three others in press. He has served on the University of Kentucky Appeals Committee and the University Sexual Misconduct Appeals Committee, and is vice-chair of a Medical Institutional Review Board. In 2017, he became vice-chair for research in psychiatry.

Sheila Vakharia, PhD
Policy Manager
Drug Policy Alliance
Sheila P Vakharia is the Policy Manager of the Office of Academic Engagement for the Drug Policy Alliance. In that role, she helps DPA staff and others understand a range of drug policy issues while also responding to new studies with critiques and analysis. Additionally, she is responsible for cultivating relationships with researchers from a wide range of disciplines aligned with DPA’s policy interests and working to mobilize academics in service of DPA policy campaigns. Dr. Vakharia’s research and teaching interests include harm reduction therapy, drug policy reform, drug user stigma, overdose and overdose prevention, and social work education. Sheila is on the Board of HAMS Harm Reduction Network and is a member of the Harm Reduction Therapy Research Group. Dr. Vakharia earned her doctorate at Florida International University’s School of Social Work.

Laura Walsh, PsyD
Clinical Psychologist, Consultant
Resolute Recovery, LLC
Laura Linebarger Walsh, PsyD, is a clinical psychologist, consultant and addictions expert on the North Shore of Chicago. She co-founded a private practice, the Wilmette Counseling Center, and a psychological services consulting company, Resolute Recovery, LLC. She earned her undergraduate degree from Texas State University in psychology with a minor in philosophy. She went on the earn her master’s and doctorate degrees from the Illinois School of Professional Psychology at Chicago in clinical psychology with a focus in psychoanalytic psychology. She won the "Emerging Scholar Award for Best Clinical Research Project" for her original research titled, “Addiction Factors Within Obesity,” as well as other awards with the Illinois Psychological Association, American Psychological Association and Kentucky Psychological Association. Walsh has long-standing experience and breadth within the field of addiction as well as key expert specialties in attention deficit hyperactive disorders, LGBT issues, and sex and sexuality. She has professionally published and presented on multiple topics and was a visiting professor for graduate studies at The Family Institute at Northwestern University, the University of Louisville, Department of Psychological and Brain Sciences, the Chicago School of Professional Psychology and the Illinois School of Professional Psychology.

Agnes Winokur, MS
Associate Laboratory Director
DEA/Southeast Laboratory
Associate Laboratory Director Agnes D. Winokur has worked for the Drug Enforcement Administration (DEA) for more than 20 years. She has served as a Forensic Chemist, a Supervisor, and a Program Manager in various locations within DEA. Agnes currently serves in the National Institute of Standards and Technology (NIST) Organization of Scientific Area Committees for Forensic Science (OSAC) Seized Drugs Sub-committee, which focuses on standards and guidelines related to the forensic analysis of seized drugs in the United States. She is a member of the International Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG), which works to improve the quality of the forensic examination of seized drugs for the international forensic community. Not only is she an active member of the American Academy of Forensic Sciences, but she is also the Co-chair of the Academy’s Opioids Committee. Her commitment to standard developing efforts in the United States and abroad is also evident through her work as Vice-chair and technical contact for numerous forensic drug related standards at the ASTM International E30 Forensic Science Committee.